Bavarian lands monkeypox vaccine contract with unnamed European country

On Thursday, as more monkeypox cases emerge across Europe, Bavarian Nordic has announced a supply contract with an undisclosed European country for its vaccine Imvanex.
Photo: Philip Davali/Ekstra Bladet, Philip Davali
Photo: Philip Davali/Ekstra Bladet, Philip Davali
by andreas lønstrup, translated by daniel pedersen

In the face of a small European outbreak of monkeypox, with the UK, Portugal, and Spain reporting confirmed cases, Bavarian Nordic has signed a contract to supply its vaccine against the infection to an undisclosed country in Europe, the company has announced in a Thursday press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading